mRNA vaccine delivery using lipid nanoparticles

mRNA vaccines elicit a potent immune response including antibodies and cytotoxic T cells. mRNA vaccines are currently evaluated in clinical trials for cancer immunotherapy applications, but also have great potential as prophylactic vaccines. Efficient delivery of mRNA vaccines will be key for their...

Full description

Bibliographic Details
Main Authors: Reichmuth, Andreas Michael (Contributor), Oberli, Matthias (Contributor), Jaklenec, Ana (Contributor), Langer, Robert S (Contributor), Blankschtein, Daniel (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Langer, Robert S. (Contributor), Blankschtein, Edmundo D (Contributor)
Format: Article
Language:English
Published: Future Science, LTD, 2017-08-03T14:33:25Z.
Subjects:
Online Access:Get fulltext